Porrazzo PFT Nasa 2006 White Paper Abstract

8/9/2019 Porrazzo PFT Nasa 2006 White Paper Abstract

1/5

P o r r a z z o 2 0 0 9 Page - 1-

Advances in Non-Invasive SalivaBased Medical Testing Systems

Using Advanced Membranes

ABSTRACT:

The Success of the Personal Fertility Testing and Reproductive

Health System (PFT 1-2-3) and the Future Potential for Saliva

Based Membrane Diagnostic Technology And Substance Abuse

Testing

SUBTITLE: PFT 1-2-3 and Advanced Diagnostic and Drug Testing Devices

PRESENTER:

E. Michael-Porrazzo, Senior Scientist and Vice-President of

Research and Development for Chain Reactions, Inc.; Co-Inventor of PFT

1-2-3 and Advanced Membrane Transducer Technologies, publishedauthor and patent holder.

OVERVIEW OF THE INVENTION:

The Invention of the PFT 1-2-3 Membrane Diagnostic

Device represents a significant

breakthrough for three reasons.

1. First, A successful commercial application for portable,reusable, inexpensive and accurate use of photonic

activation using membranes to induce crystal growth in

biological fluids for non-invasive medical diagnotistics.

The inventors research and development position with the

PFT membrane technology was that the time before

ovulation is where a women is most likely to conceive.

2. Recent medical research appears to validate this position.

It was previously thought that a womens most fertile timewas at and just after ovulation. Therefore current medical

testing methodologies which analyze LH factor have now

been found to be inappropriate. This is because the surge in

LH occurs at or just after ovulation. More importantly, a

women seeking to avoid conception could easily become

pregnant if she relied upon the results of these kind of


2/5

P o r r a z z o 2 0 0 9 Page - 2-

medical tests since sperm could

survive well into the most fertile

period, (before ovulation). This is

because the LH medical test

would provide the user with a

positive result just as she had

ovulated. PFT therefore representsone of the easiest to use, accurate

personal devices for fertility

testing and positive ovulation

detection.

3. The PFT 1-2-3 is able to provide awide range of information from the crystalline patterns that are displayed from the Universal

Indices. Universal Indices are the inventors discovery which seem to open an entirely new non-

invasive medical diagnostic capability.

4. Third, the use of advanced membranes in products like the PFT may open the future to new kindsof non-invasive testing products and methodologies, including low cost, reliable and accurate

substance abuse testing systems.

OVERVIEW AND DESCRIPTION OF CAPABILITY:

This technology relates to an advanced membrane health analysis system that is applicable to

both men and women. In particular the device is a portable, hand-held, integrated unit which is

manufactured out of plastic. The unit can be disposable for hygienic purposes, or cleaned or sterilized

for repeated use as desired. The device has numerous aspects. These main aspects include: (1) The

use of any body fluid, but especially saliva to perform the

analysis test upon. (2) The current device is a plastic,

completely integrated, portable, self-contained and self-focusing Examination System which relies on a visual

reference system making it language independent; (3)

The current device uses a Test Area Section with

replaceable slides where different, specific wavelengths

of light are employed; (4) The embodiment of compound

test areas in the current device allows multiple Tests to

be conducted simultaneously with the capability to

immediately perform two or more Tests simultaneously

using different body fluids or secretions; (5) An

electronic interface device is under development which

can provide a novel battery powered microprocessor

system to automatically perform Testing or BatchTesting.


3/5

P o r r a z z o 2 0 0 9 Page - 3-

Current commercial application has provided a highly reliable, low cost, unique, immediate

testing methodology employing any and all female fluids or secretions called Positive Fertility

Testing, PFT. The PFT embodiment of the technology provides one of the most accurate

indicators of positive ovulation whereby

a woman may pinpoint times of

greatest fertility, thereby knowing the

optimum time period for achieving oravoiding pregnancy. Therefore PFT

may be used as a highly effective

method to support birth control. The

PFT may also be used to identify

hormonal imbalances, irregular cycles

or infertility; introduce young women

to their fertility cycle, sexuality and

health.

Another aspect of the

present PFT Invention is that it greatly

simplifies the testing process and results in numerous economies. For instance, unlike many alternative

systems, the PFT does not require a prolonged period of time to perform the analysis, nor are

comparative tests required to get extremely accurate readings. However, the PFT can perform

multiple confirming tests simultaneously by using the same or different female fluid or secretions. In

this way the Invention can immediately provide information on the positive or negative status of a

womens fertility and the condition of her reproductive health.

The PFT may be used without extensive training. Furthermore, the device and its

associated processes are based upon a visual reference system designed to be language independent

so that it can be used anywhere in the world and in areas where the user may in fact be illiterate.

Because the PFT can tell the user when positive ovulation has occurred it can help awoman prevent or postpone pregnancy, or assist a woman in becoming pregnant naturally, as desired.

The Invention is accurate during any reproductive situation, including breastfeeding, pre-menopause,

after the discontinuation of medication including, contraceptive pills, and during times of illness or

stress. These are all time which medical research cofirm a women can become pregnant. For women

having difficulty becoming pregnant the PFT can help identify many specific infertility problems

relating to reproductive health.

The PFT can support or reduce the use of other contraceptives and support or reduce

the use of other ovulation test methods. However, the PFT may also be used as a stand-alone birth

control device or reproductive health tool. Other prior art devices are physically invasive, time

consuming, cumbersome and onerous. Traditional prior art devices interrupt or halt intimacy. For

women using the PFT , loving and sexual feelings can flow into spontaneous lovemaking. The PFTnot only avoids the interrupting of lovemaking, but it also eliminates the mess and often harmful side

effects of contraceptive devices and chemicals. The PFT s visual display gives information directly

to the woman, thus providing self-confidence, independence and security knowing just when she can

or cannot get pregnant.

Given the Presidents mandates regarding the problem of teenage unwed pregnancy in the


4/5

P o r r a z z o 2 0 0 9 Page - 4-

United States and concerns of overpopulation PFT represents a highly effective and reliable

international sex education/awareness tool. Given the high incidence and burdened support costs for

unwed pregnancy in the United States Military and among their dependents the current low-cost PFT

device could be issued to each active duty service man as a preventative measure. It has been

identified that unwanted pregnancy is a

very significant problem in the

United States, with The NationalInstitute of Health stating that more

than fifty percent of all pregnancies

are unintended. Unintended

pregancy and failure to have proper

fertility awareness education creates

personal stress and a tremendous

financial burden of hundreds of

millions of dollars in support, time

and personnel which depletes

funding resources that could be

channeled to other programs. The

availability of low cost, reusable,

easy to use non-invasive diagnostic

tools like PFT could free up

valuable labor resources and cause

direct cost savings. Deploying PFT

in quantity could allow the

redirection of a significant amount

of funds for other programs.

The PFT can also be a check

step for sexual partners being

untruthful about using birth controlpills or other contraceptives.

Because it is highly portable,

personal and reusable the PFT issued to

women and men would have immediate applicability either to replace or augment existing systems.

The PFT can also be used when and where traditional contraceptive technologies are not available,

cause allergic reactions, or are not used for religious or other reasons.

This non-invasive Membrane Diagnostic Technology may be directly applicable to other

diagnostic capabilities including Saliva Based Membrane Drug and Substance Abuse Testing for

alcohol, marijuana, cocaine, and other illegal substances. Further, the inventors believe that non-

invasive testing methodologies using advanced membrane technologies like the PFT are

fundamentally important to future medical diagnostics.


5/5

DEMONSTRATIONDemonstration of the simplicity of the PFT 1-2-3. Discussion of Medical Tests and Protocol

of Current PFT 1-2-3 Technology. Short 7 minute video may be shown.

Discussion of the commitment needed for future applications of the Saliva Based Membrane

Medical Diagnostic Technology And the potential to create new testing systems for substance abuse

diagnostics.

P o r r a z z o 2 0 0 9 Page - 5-

TECHNICAL CONCEPT:

The PFT is a Saliva Based Membrane

Diagnostic Technology And Testing System and is a

method of diagnosing the fertility status, health

condition of the test subject. The technology employs

an integrated Positive Membrane Testing Apparatus for

both propagating and observing

Universal Indices found in

any human fluids or

secretions, especially saliva, the

method and apparatus comprising a viewing and magnifying area means and

an optically accessible and photonically energized sample collection and

examination area means so that sample(s) of any human fluids or secretions

deposited on the sample collection and examination area means are under

the influence of evaporative processes and the application of light waves

such that crystalline formations of Universal Indices are caused to be

propagated and revealed when observed under viewing and magnifying area

means, thus providing for the qualitative and quantitative diagnosis of

fertility status, health condition and potential levels of substance abuse of the

sample donor. The tests may be self-administered, or administered by

medical personnel.

CURRENT STATE OF DEVELOPMENT:

The Current PFT Membrane technology has been released

commercially since 1/96. The PFT devices are now available in any quantity

for immediate deployment. Qualified educational personnel are at hand to

train designated personnel. Training video, literature and multi-media

material are available. PFT is being evaluated by various agencies including,

NASA, US Army, NRAD, NIH, AAFES, among others.

Contact Information: Michael Porrazzo, CTO of MODDHA-Porrazzo,

808.298.6508 email: [email protected]
mailto:[email protected]:[email protected]:[email protected]

Documents

Porrazzo PFT Nasa 2006 White Paper Abstract